REFRACTORY HEMATOLOGIC MALIGNANCY
Clinical trials for REFRACTORY HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for REFRACTORY HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo shows promise for tough brain cancer
Disease control Recruiting nowThis study tests an experimental oral drug called emavusertib (CA-4948), taken alone or with ibrutinib, in adults with relapsed or refractory primary central nervous system lymphoma (PCNSL). The trial has multiple parts to find the safest dose and see if the drug shrinks tumors. …
Matched conditions: REFRACTORY HEMATOLOGIC MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New app aims to make End-of-Life conversations easier for cancer patients
Symptom relief Recruiting nowThis study tests a mobile app called PACT that helps people with advanced cancer talk about and plan the care they would want if they couldn't speak for themselves. The app involves patients and their loved ones in these discussions. Researchers want to see if the app is easy to …
Matched conditions: REFRACTORY HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Gene therapy recipients monitored for 15 years in safety study
Knowledge-focused Recruiting nowThis study does not test a new treatment. Instead, it follows 500 people who have already received genetically modified cell therapy for blood cancers. Researchers will check for any delayed side effects over 15 years, as required by the FDA. The goal is to understand long-term r…
Matched conditions: REFRACTORY HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New european effort matches kids with relapsed leukemia to smarter treatments
Knowledge-focused Recruiting nowThis study helps doctors choose the best available therapy for children and young adults with relapsed or hard-to-treat blood cancers. A team of experts reviews each patient's tumor markers and history to recommend a personalized treatment plan. The study does not give any new dr…
Matched conditions: REFRACTORY HEMATOLOGIC MALIGNANCY
Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC